A/Professor Kathy Wu is the founding Head of St Vincent's Clinical Genomics, a HGSA-certified Clinical Geneticist, physician scientist, and educator. Kathy is a senior staff specialist at St Vincent’s Public & Private Hospitals and St Vincent’s Clinic, with academic affiliations with the UNSW, University of Sydney, University of Notre Dame Australia, the Garvan Institute of Medical Research, and the George Institute for Global Health. Kathy is committed to translating genomics research to inform precision healthcare and improving individual and categorical patient outcomes. Kathy is one of the clinician pioneers in Australia to lead a real-world pharmacogenomics implementation body of research and has been awarded $6 million+ in MRFF Research Grants since 2020 to continue her passion in pharmacogenomics research to improve treatment outcomes for people with Major Depressive Disorder.

Dr Saya is a senior research fellow and an academic genetic counsellor at the University of Melbourne Department of General Practice and Primary Care. Dr Saya's expertise is the implementation and translation of genetic and genomic tests into primary care and general practice and the conduct of clinical trials in this field.

Professor Luke Hesson is a Clinical Scientist with a Ph.D in Clinical Genetics and is a Fellow of the Faculty of Science of the Royal College of Pathologists of Australasia (RCPA). He is Department Manager of Genetics at Douglass Hanly Moir Pathology, and provides scientific supervision of genetic testing including pharmacogenomics and comprehensive genomic profiling for cancer. He is affiliated with University of Technology Sydney where he lectures in genetics, epigenetics, cancer, molecular pathology and precision medicine. Luke is Chair of the Australasian Society for Diagnostic Genomics (ASDG) and co-Chair of the RCPA Pharmacogenetic Advisory Group, which recently provided guidance for prescribers, pharmacologists and pathologists regarding clinical indications for pharmacogenomics testing in Australia.

Christine Lu, MSc, PhD is a Professor at the Sydney Pharmacy School and Chair of Clinical Pharmacy at Northern Sydney Local Health District. A pharmacist, health policy scientist, and pharmacoepidemiologist, she holds an MSc in Biopharmaceuticals and a PhD from the University of New South Wales. Dr. Lu completed her postdoctoral training at Harvard Medical School, where she later served as Associate Professor at both Harvard Medical School and the Harvard Pilgrim Health Care Institute before joining the University of Sydney. Internationally recognised for her impactful research, Dr. Lu’s work addresses critical clinical pharmacy and health system challenges. Her research focuses on: 1. The effects of health policies and programs on medication use and outcomes; 2. Access to and quality use of pharmacogenomic testing and genomic sequencing; and 3. The use, access, and outcomes of high-cost medicines. • Academic Profile: https://www.sydney.edu.au/medicine-health/about/our-people/academic-staff/christine-lu.html